HLA-class II promoters contain a set of conserved regulatory regions necessary for constitutive and induced gene expression. For the HLA-DQB as well as for the DRB1 promoter sequence, polymorphisms with influence on gene expression have been reported. In contrast to these data we could show that there is very limited allele-specific polymorphism among the HLA-DRB1 promoter alleles. In a long range PCR we amplified a DNA sequence containing the promoter and the second exon of the DRB1 gene in one fragment. Nested PCR products of this PCR fragment for the promoter and for the second exon were analysed by DNA sequencing to allow the linkage of a promoter to its DR allele. Most investigated DRB1 alleles exhibited the same promoter consensus sequence except for two point mutations. An A to T transversion (position −70 bp) was closely associated with DRB1*08, whereas a C-deletion (position −30 bp) was most commonly observed together with DRB1*10. Both polymorphisms did not influence promoter activity in luciferase reporter gene assays. Genes and Immunity (2001) 2, 211-215.
Introduction
Within the highly polymorphic HLA-class II genes HLA-DR genes show the highest variability. The genetic organisation of the DR subregion on the short arm of chromosome 6 varies according to the haplotype. A single nonpolymorphic ␣-chain and a highly polymorphic DR␤ chain coded for by the DRB1 locus are always expressed, whereas certain haplotypes contain one additional DR␤ chain of limited polymorphism 1,2 DRB5 in the DR51 group, DRB3 in the DR52 group and DRB4 in the DR53 group. In addition, there are also varying numbers of pseudogenes present on the different haplotypes (DRB9 in the DR8 group, DRB6 and DRB9 in the DR1 and DR51 groups, DRB2 and DRB9 in the DR52 group, and DRB7, DRB8 and DRB9 in the DR53 group of haplotypes).
DR molecules serve as restriction elements for CD4 + T lymphocytes which are required for both cellular and humoral immune responses. 3, 4 The density of these molecules on the surface of antigen presenting cells as a result of the strength of gene expression influences the character of the resulting T cell response. 5, 6 Several groups have reported allele-specific sequence polymorphisms in the DRB1 promoter with influence on gene expression. [7] [8] [9] [10] [11] [12] [13] However, data so far are contradictory concerning the allele-specific DNA sequences and the extend of polymorphism. According to these data two interdependent levels of regulation of antigen presentation were postulated: one resulting from the allelic polymorphism of the peptide binding site, and one depending on the differential expression of DR genes because of polymorphisms in the promoter region. 10 This could be of importance in several DR-associated infectious and autoimmune diseases.
We established a long range PCR strategy 14, 15 amplifying the DRB1 promoter and the second exon of the DRB1 gene in a single ෂ10 kb DNA fragment. The second exon is the most polymorphic one in the DRB1 gene and its sequence is characteristic for each allele. By sequencing the second exon we were able to unambiguously identify to which DRB gene and especially to which DRB1 allele an actual promoter sequence belonged. Furthermore, screening of a genomic library was performed in order to obtain the DR7 promoter sequence.
Results and discussion
Like all HLA-class II promoters the DRB1 promoters contain a set of conserved regulatory elements which are important for both constitutive and INF-␥ induced gene expression. 16, 17 From 5′ to 3′ direction these elements are the W-box which contains the 7 bp S box, the X box which consists of the overlapping elements X1 and X2, the Y box which contains an inverted CCAAT element, the CCAAT box, and the TATA box.
The HLA-DQB regulatory region has been shown to exhibit allelic polymorphisms resulting in variable transcriptional activity. 18 From several groups allele-specific sequence polymorphisms for the DRB1 promoter especially in the functional boxes have been reported as well. [7] [8] [9] 11, 12 The differences in promoter sequence have been demonstrated to influence the transcriptional activity of the promoter. 9, 13 However, the extent of sequence variation in the DRB1 promoter is unclear as data presently are contradictory probably due to the complex organisation of the DRB gene region and sequence homologies of the DRB1 alleles to other DRB genes.
For promoter amplification all published studies used 3′ primers lying upstream of or in the first exon of the DRB1 gene, which is not characteristic for the different DRB1 alleles. Thus an unequivocal allele assignment was not possible as the highly polymorphic and allele-specific exon 2 was not included in the amplification product.
To circumvent this problem and to ensure to which DRB gene and to which DRB1 allele an investigated promoter belonged, we established a long range PCR amplifying a DNA fragment of ෂ10 kb containing the promoter and the second exon of the DRB1 gene. In a second reaction a nested PCR amplification of the promoter region and of the second exon was carried out using the product of the long range reaction as a template (see Figure 1) . By DNA sequencing of the resulting PCR products an unambiguous assignment of a given promoter sequence to its respective DR allele was possible because the second exon DNA sequence is characteristic for the corresponding DRB1 allele.
This strategy worked well for all investigated DRB1 alleles except for those of the DR53 haplotype group (DRB1*04, *07, and *09), probably because this is the most complex haplotype with one additional expressed DRB locus and three DRB pseudogenes. The resulting PCR products were not specific for DRB1 but for DRB4, the second expressed DRB gene in the DR53 haplotype.
The screening of a genomic library homozygous for DRB1*07 was performed because analysing the DR53 promoter in a single phage clone would circumvent the problem of unwanted amplification of DRB genes other than DRB1. Several phage clones could be obtained each containing the second exon of the DRB1*0701 gene and also the corresponding promoter as confirmed by PCR and subsequent DNA sequencing of the PCR products. Interestingly, though homozygous for the present DRB1* Figure 1 Diagram of the PCR strategy for amplifying the DRB1 promoter. First, in a long range PCR a ෂ10 kb DNA fragment is amplified spanning from the DRB1 promoter region to the end of the second exon of the gene. In the second step, proceeding from the product of the first PCR as template, nested PCRs of the promoter region and of the second exon were performed. Both nested PCR products were analysed by DNA sequencing to ensure to which DRB1 allele a present promoter sequence belonged. 07017 allele two different promoter alleles were isolated from the library (see below).
In contrast to previously published data our results could not confirm the extensive allele-specific polymorphism so far described in literature for the DRB1 promoter. Most investigated DRB1 promoter alleles (DRB1* 01, *15, *07, *11, *12, *13, *14, *17) showed a common consensus sequence with the exception of two single nucleotide polymorphisms lying outside of regulatory boxes. The first was a C-deletion at position −30 upstream of the TATA box and the second a A → T transversion 5 bp upstream of the CCAAT box at position −70 (see Figure 2 ). The C-deletion was found in a DRB1*1101-and in a DRB1*1301-positive sample and in one of the DRB1* 0701 promoter sequences obtained from the genomic library. It has formerly been described by Emery et al 8 to be specific for the DRB1*1401 allele. The A → T-transversion was observed in the other DRB1*0701 allele from the genomic library, in a DRB1*0101-and in both DRB1*0801-homozygous individuals. This transversion has been reported to be specific for DRB1*0801. 9 The two mutations were never found together in a single promoter sequence.
The analysis of the other alleles of the DR53 haplotype except for DRB1*0701 was not possible because to date no primer pair could be found to specifically amplify the DRB1 allele out of the additional DRB genes and pseudogenes present in this haplotype.
To estimate the frequency of the two polymorphisms in the population and to determine whether they are alleles or rare mutations, a population study was performed. In a group of 56 unrelated healthy Caucasian blood donors the A → T transversion was found in five individuals (one individual homozygous, five of 56 individuals with the T allele and DRB1*08 compared to 51 individuals without DRB1*08 and without the T-allele; allele frequency 0.11). All five DRB1*0801 positive individuals carried the T allele. However, in the long range PCR studies we also observed this exchange on DRB1*01 and *07. This transversion appears to be closely associated but not specific for DRB1*08.
The C-deletion was observed in 11 of 56 individuals. Two individuals were homozygous for this polymorphism giving an allele frequency of 0.12. It was present in four of four DRB1*10-positive individuals (P Ͻ 0.001 with Fisher's exact test) but also with several other DRB1 alleles. As DRB1*10 is a rare allele we investigated five additional samples with this allele, which were all heterozygous for the deletion. The C-deletion is associated with DR10 but also occurs on other DRB1 haplotypes.
To investigate the functional consequences of the nucleotide variations in the DRB1 promoter the DRB1 promoter variants described above were checked for their transcriptional activity. PCR products of the three different DRB1 promoter sequences were cloned into a TA cloning vector and then subcloned in the pGL3 luciferase vector. These reporter vector constructs were transiently transfected into a human lymphoblastoid B cell line (Raji) and luciferase activity was measured.
The three different DRB1 promoter alleles showed no significant differences in transcription efficiency (see Figure 3 , expressed as mean values of the four transfections for each promoter construct with standard deviations). Thus, the two deviations from the consensus promoter sequence do not influence the transcriptional activity of the DRB1 gene.
Because of this promoter sequence conservation among the different DRB1 alleles, maintenance of a constant amount of DRB1 molecules irrespective of the present DRB1 allele seems to be important for effective immune responses. In a long range PCR using primers listed in Table 1 a DNA fragment of ෂ10 kb was amplified extending from the beginning of the DRB1 promoter at position −206 to the end of the second exon of the DRB1 gene at codon number 87 (see Figure 1) . After initial denaturation for 2 min at 94°C and a 'touch down' 19 with annealing temperatures decreasing from 68 to 65°C, 10 cycles with 94°C for 10 s, 65°C for 30 s and 68°C for 10 min were carried out followed by 22 cycles of 94°C for 10 s, 65°C for 30 sec and 68°C for 10 min 20 sec with a prolongation of 20 sec in each cycle. The reaction was completed by a final extension step of 68°C for 15 min.
Materials and methods

PCR
The resulting PCR product was diluted (1:100 to 1:100 000 according to the amount of template from the first PCR, assessed by agarose gel electrophoresis of the PCR product) and used as template for two different nested PCRs 20 (see Figure 1 ). The first amplified the DRB1 promoter region from nucleotide position −200 to +94 with the primers listed in Table 1 . PCR was carried out with an initial denaturation of 4 min at 94°C followed by a 'touch down' from 66 to 59°C, 35 cycles of 94°C for 1 min, 58°C for 1 min and 72°C for 1 min with a final extension of 7 min at 72°C.
In order to identify the corresponding DR allele with this long range PCR product a second nested PCR was carried out using the primer pair listed in Table 1 resulting in a PCR product covering codons 7 to 94 of the second exon of the DRB1 gene. Amplification was performed with an initial denaturation of 4 min at 94°C, a 'touch down' from 66 to 63°C, 35 cycles of 94°C for 1 min, 62°C for 45 s, and 72°C for 1 min followed by a final extension of 7 min at 72°C.
Both nested PCR products were sequenced using the dideoxy chain terminator method 21 and analysed in an ABI Prism 310 DNA sequencer (PE Biosystems, Weiterstadt, Germany).
Gene library screening for the DR7 promoter sequences A genomic library homozygous for DRB1*0701 in EMBL3 -phages 22, 23 was screened for a clone containing the promoter and the second exon of the DR7 gene. The first screening was carried out with a Digoxigenin-coupled PCR probe (PCR DIG Labeling Mix, Roche Diagnostics) consisting of the second exon of the DR7 gene generated with the primers listed in Table 1 . After an initial denaturation of 4 min at 94°C a 'touch down' with annealing temperatures ranging from 68 to 64°C was performed followed by 35 cycles of 1 min at 94°C, 45 sec at 63°C, and 30 sec at 72°C. The final elongation was 7 min at 72°C. Detection was performed by chemiluminescence with the DIG Luminescent Detection Kit (Roche Diagnostics).
Positive clones were picked, plated out and then further hybridized against a Digoxigenin-coupled PCR product of the DRB1 promoter generated in the above described manner for the nested PCR. Clones positive in both hybridizations were propagated. -DNA was iso- 24 and then subjected to PCR amplifications of the promoter and second exon regions of DR7 with the primers and conditions also used for generation of the respective hybridization probes. PCR products were sequenced and analysed as described above.
Plasmid constructions for functional promoter analysis
Nested PCR products of the three different DRB1 promoter alleles identified in the present study (consensus sequence −30C, −70A, C-deletion −30del, −70A and A → T −30C, −70T) were amplified using primers and conditions described above were cloned into the pCR2.1 TA vector (Invitrogen, Groningen, Netherlands). After transformation of E. coli (strain INV␣′, Invitrogen Groningen, Netherlands), selection, and propagation, recombinant plasmid DNA was prepared. Following a digestion with the restriction enzymes XhoI and SacI these fragments were subcloned into the pGL3 basic plasmid (Promega, Mannheim, Germany). After transformation in E. coli (strain JM109, Promega), selection, and propagation, pure plasmid DNA was prepared using the QIAGEN Plasmid Midi Kit (QIAGEN Hilden, Germany). Constructs were analysed on an ABI 310 DNA sequencer to verify the insert sequence and orientation.
Luciferase assay
Raji cells (human lymphoblastoid B cell line) were grown in RPMI 1640 medium supplemented with 5% FCS, 100 g/ml penicillin and streptomycin and 2 mm L-Glutamin at 37°C with 5% CO 2 . 0.7 × 10 7 cells were transiently transfected during the log phase of their growth with ෂ10 g DNA of one of the three different plasmid constructs and 2.5 g of a ␤-galactosidase control vector (pcDNA3.1/HisB/lacZ, Invitrogen) by the DEAE-dextran method. After transfection cells were incubated for 42 hours, harvested, and lysed in Reporter Lysis Buffer (Promega). Cell lysates were assayed using kits for luciferase and ␤-galactosidase according to the manufacturer's instructions (Promega; Tropix Inc, Bedford, USA). Each transfection was performed four times. Luciferase and ␤-galactosidase activities were measured using a Berthold luminometer. Luciferase values were normalized against the ␤-galactosidase values.
Population study
To determine whether the two-point mutations in the DRB1 promoter are common alleles or rare mutations DNA samples of 56 unrelated Caucasian individuals were investigated.
Mutation detection by fluorescence resonance energy transfer for the A to T transversion
The A → T transversion at position −70 was analysed by performing a PCR reaction on a LightCycler™ (Roche Diagnostics) using two flourophore-coupled oligonucleotide probes that hybridize to adjacent sequences on the target DNA in a head-to-tail arrangement. The marker dyes come in close proximity and between them a fluorescence resonance energy transfer (FRET) occurs. The fluorescin (FITC)-coupled 'anchor' probe acts as a donor, the LightCycler Red 640-coupled 'sensor' probe is the acceptor, and both block extension of their 3′ ends.
PCR was carried out with genomic DNA using the same PCR primers as for the nested PCR of the DRB1 promoter and the two hybridization probes listed in Table 1 . Conditions for cycling were 95°C for 5 min, followed by 45 cycles of 95°C for 10 sec, 55°C for 10 sec, and 72°C for 15 sec. Finally, temperature was raised for 1 min to 95°C for complete dissociation of double strands, then cooled to 45°C for 2 min to allow binding of the hybridization probes followed by slow heating to 80°C while fluorescence was monitored to detect dissociation of the 'sensor' probe from the template. The A → T transversion causes an increase in the melting temperature of the 'sensor' probe, while for templates with A at position −70 the melting temparature is lower. Persons homo-or heterozygous for the transversion can easily be detected by their melting curves.
Mutation detection by SNaPshot analysis ('minisequencing') for the C deletion
Screening for the C-deletion at position −30 was performed by SNaPshot analysis (ABI Prism SNaPshot™ ddNTP Primer Extension Kit; Weiterstadt, Germany) based on the extension of an unlabeled oligonucleotide primer with a single dideoxy nucleotide.
PCR was performed using the same conditions and primers (see Table 1 ) as in the nested PCR of the DRB1 pro-moter. 0.15 pmol of the resulting PCR product were subjected to thermal cycling with the four differently fluorescence-labeled ddNTPs and an unlabeled primer hybridising to the PCR product with its 3′ end exactly one nucleotide 5′ of the position of interest (see Table 1 ). Corresponding to the template sequence primer is extended at its 3′ end with a single ddNTP, which is a ddTTP (red fluorescence) in the case of a C-deletion, and a ddCTP (yellow fluorescence) in the other case. PCR conditions were 32 cycles of 96°C for 15 sec, 50°C for 15 sec, and 60°C for 30 sec. Samples were analysed in an ABI Prism 310 DNA sequencer (PE Biosystems).
